Osteoarthritis and Bone Disorders News

Women with osteoporosis are not being identified and treated at sufficient rates, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.

Research linking fluctuations in bone marrow lesions with pain fluctuations may suggest that targeting these lesions could successfully reduce osteoarthritis pain, according to a speaker at the 2020 Congress of Clinical Rheumatology-West.

Among patients with, or at risk for, knee osteoarthritis, knee pain patterns could potentially be linked to peripheral ascending pain mechanisms and descending modulatory mechanisms, according to data published in Arthritis Care & Research.

Among patients with osteoarthritis, increased tanezumab doses are associated with a higher incidence of abnormal peripheral sensation compared with NSAIDs, according to a speaker at the 2020 American Neurological Association Annual Meeting.

High-intensity physical activity throughout early life can help prevent osteoporosis and maximize peak hip strength later, according to data published in JAMA Network Open.

Novel therapies are providing hope in osteoporosis, but questions surrounding optimal treatment regimens remain, according to a presenter at the 2020 Congress of Clinical Rheumatology-East.

An extract made from Curcuma longa, commonly known as turmeric, outperformed placebo for the treatment of osteoarthritis-related knee pain in older adults but had no significant impact on knee effusion-synovitis or cartilage composition, data showed.

A number of compounds and therapeutic approaches moving through the pipeline may soon enrich treatment paradigms for osteoarthritis, according to a presenter at the 2020 Congress of Clinical Rheumatology-East.

Interleukin-1 inhibition with canakinumab may substantially reduce rates of total hip and knee replacement, as well as osteoarthritis symptoms, according to data published in the Annals of Internal Medicine.

When presented with a range of treatment options, patients with osteoarthritis reported that the most important outcomes are disease progression and improving pain and walking, noted researchers in Seminars in Arthritis and Rheumatism.